Cancer remains the largest cause of death from disease for children in the UK and NCCA UK Chief Executive Bettina Bungay Balwah says the funds raised at the Regatta will allow the charity to "move forward with an exciting and ground-breaking clinical trial".
This trial will be conducted as part of an initiative called INBRACED (International Research and Collaboration for Effective Delivery), which draws together charities from the US, UK and wider Europe in order to make funds available for the development of new and more effective therapies.
It will be the first ever international trial for relapsed neuroblastoma - an aggressive cancer of the nervous system, which causes more deaths than any other cancer amongst the under-fives.
Many children experience life-threatening relapses after achieving remission and some gaining no benefit whatsoever from current treatment options.
Ms Balwah added: “Currently there is no established cure for children who have relapsed from this illness. By giving children in different countries the same promising experimental treatment at the same time, trials can generate results faster whilst delivering the most exciting therapy options for more children."
The regatta, to be held at the Royal Yacht Squadron, is being organised in partnership with Sunsail Events, the leading sailing and events company in the UK, and will utilise the only perfectly matched fleet of yachts in the UK, Sunsail First Match 40s.
Simon Boulding, Sunsail events director said: “Sunsail is delighted to support the NCCA’s first regatta and will do our utmost to assist them achieving their fundraising target.”
To find out how you can get involved with the event visit www.khpr.co.uk